Concert Pharmaceuticals, Inc. (CNCE) |
| 8.37 0 (0%) 03-03 16:00 |
| Open: | 8.38 |
| High: | 8.55 |
| Low: | 8.35 |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | -2.64 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 8.55 |
| Resistance 1: | 8.46 |
| Pivot price: | 8.37 |
| Support 1: | 8.31 |
| Support 2: | 6.91 |
| 52w High: | 8.55 |
| 52w Low: | 2.72 |
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Financials
| EPS | -3.170 |
| Book Value | 2.780 |
| PEG Ratio | 0.00 |
| Gross Profit | -1.145 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -287.97 |
| Return on Assets (ttm) | -38.5 |
| Return on Equity (ttm) | -108.7 |
Company news
Thu, 16 Feb 2023
Concert Pharmaceuticals: Negative Spread But Interesting CVR (NASDAQ:CNCE) - Seeking Alpha
Thu, 19 Jan 2023
Sun Pharma to Acquire Concert Pharmaceuticals - citybiz
Thu, 19 Jan 2023
Sun Pharma To Acquire Concert Pharma - RTTNews
Thu, 19 Jan 2023
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata - Business Wire
Mon, 14 Nov 2022
Further weakness as Concert Pharmaceuticals (NASDAQ:CNCE) drops 13% this week, taking five-year losses to 77% - Yahoo Finance
Mon, 23 May 2022
Concert Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata - Business Wire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
